Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Find out Which Dividend Growth ETF Has Low Fees and what to look for in expense ratios. Get tips to compare funds effectively.
28,299 articlesEli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
PayPal sits near $42 after a tough year, sparking a lively debate on whether the stock is a bargain or a trap as Q4 r...
A high-profile investor move has eyes turning to a GLP-1 stock with big growth potential. Here’s what it means for ri...
Palantir stock investors just got new cues from the Street. This guide explains what the headlines might mean, how to...
MP Materials is turning a quiet corner in the US defense supply chain, with Pentagon-backed pricing and a plan to bui...
Michael Burry has added a Micron short, expanding a wager that AI-driven chip stocks may soon pull back. The move com...
Marvell Technology is about to join the S&P 500 on June 22, 2026, after a 57% rally in the last 30 days. Market watch...
Datadog's CEO recently sold a sizable block of shares. This article breaks down the numbers, explains why insiders se...
As the Nasdaq pauses, history suggests a potential rebound. This guide dives into two high-growth stocks poised to ri...
Promotional events like Prime Day grab headlines, but the real driver of Amazon stock is its cloud arm, AWS. This gui...
The stock market CAPE ratio has climbed near 40, a level last seen before major crashes in 1929 and 1999, prompting c...
As AI compute ramps up, memory has become a bottleneck. Intel’s 2021 $9 billion NAND sale to SK Hynix is drawing rene...